Dr. John Buse, MD

• Endocrinology, Diabetes & Metabolism

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Duke University

  Medical School, 1986

• English

• Spanish

• Islets Transplantation at a Crossroads - Need for Urgent Regulatory Update in the United States: Perspective Presented During the Scientific Sessions 2021 at the American Diabetes Association Congress, 2022-01-06

• Synthetic beta cells for fusion-mediated dynamic insulin secretion, 2017-10-30

• Endothelial Dysfunction: Associations with Exposure to Ambient Fine Particles in Diabetic Individuals, 2008-07-31

• Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2), 2017-09-15

• Use of Comprehensive Recruitment Strategies in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Multi-Center Clinical Trial, 2023-06-17

• H2O2-Responsive Vesicles Integrated with Transcutaneous Patches for Glucose-Mediated Insulin Delivery, 2017-01-04

• Salivary proteins associated with hyperglycemia in diabetes: a proteomic analysis, 2013-12-17

• BMI Change, Fitness Change and Cardiometabolic Risk Factors Among 8thGrade Youth, 2013-06-03

• Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetes, 2020-08-05

• Cardiometabolic Risk Assessments by Body Mass Indexz-Score or Waist-to-Height Ratio in a Multiethnic Sample of Sixth-Graders, 2014-07-14

• Re-engineering The Clinical Research Enterprise in Response to COVID-19: The Clinical Translational Science Award (CTSA) experience and proposed playbook for future pandemics, 2021-01-01

• Medications for type 2 diabetes: how will we be treating patients in 50 years?, 2015-03-14

• Effect of Glucagon-like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors on Colorectal Cancer Incidence and Its Precursors, 2016-05-10

• Characteristics and Delivery of Diabetes Shared Medical Appointments in North Carolina, 2020-03-22

• Association of cardiac and vascular changes with ambient PM2.5in diabetic individuals, 2010-06-02

• Bioresponsive Microneedles with a Sheath Structure for H2O2and pH Cascade-Triggered Insulin Delivery, 2018-02-26

• Sodium-Glucose Cotransporter-2 Inhibitor Use and Risk of Lower-Extremity Amputation: Evolving Questions, Evolving Answers, 2019-03-04

• More realistic power estimation for new user, active comparator studies: an empirical example, 2015-09-11

• Effect of relative weight group change on NMR spectroscopy derived lipid particle size and concentrations among adolescents, 2014-02-05

• Predicting Major Adverse Limb Events in Individuals With Type 2 Diabetes: Insights From the EXSCEL Trial, 2021-03-18

• 4299 The University of North Carolina CTSA Hub (NC TraCS) Service Evaluation: Using Customer Feedback to Improve Services, 2020-06-01

• Hypertension Control in Adults With Diabetes and Recurrent Cardiovascular Events: Global Results From the TECOS Trial, 2017-08-28

• Microneedle Integrated with Pancreatic Cells and Synthetic Glucose-Signal Amplifiers for Smart Insulin Delivery, 2016-03-01

• Three approaches to glucose monitoring in non-insulin treated diabetes: a pragmatic randomized clinical trial protocol, 2017-05-25

• A genome-wide study of lipid response to fenofibrate in Caucasians: A joint analysis of the GOLDN and ACCORD studies, 2016-03-11

• Plasmid-Encoded Proinsulin Preserves C-Peptide While Specifically Reducing Proinsulin-Specific CD8+T Cells in Type 1 Diabetes, 2013-06-26

• Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11-14 year-olds: The HEALTHY Study, 2016-05-04

• Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: efficacy and safety from a randomized double-blind trial, 2018-10-10

• Salivary Metabolomics of Well and Poorly Controlled Type 1 and Type 2 Diabetes, 2022-08-24

• Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE, LEADER and SUSTAIN-6 cardiovascular outcomes trials, 2020-05-18

• Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin - A DEVOTE subanalysis (DEVOTE 10), 2019-04-01

• Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes, 2023-09-08

• Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response, 2016-08-17

• Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial, 2019-10-22

• Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study, 2014-09-10

• Chronic Exposure to Arsenic and Markers of Cardiometabolic Risk: A Cross-Sectional Study in Chihuahua, Mexico, 2015-06-12

• LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ, 2016-06-02

• Performance of a computable phenotype for identification of patients with diabetes within PCORnet: The Patient-Centered Clinical Research Network, 2019-01-24

• Advances in Transdermal Insulin Delivery, 2018-12-08

• The Impact of Metformin Use on the Cardiovascular Effects of DPP-4 Inhibitors: an Analysis of Medicare Claims Data 2007-2015, 2018-11-20

• Genetic Variants inHSD17B3,SMAD3, andIPO11Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes, 2017-11-03

• Initial injectable therapy in type 2 diabetes: key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin, 2019-06-27

• Enrollment of underrepresented racial and ethnic groups in the Rare and Atypical Diabetes Network (RADIANT), 2023-01-01

• Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes and Moderate Renal Impairment (Chronic Kidney Disease Stage 3A) The DERIVE Study, 2018-07-10

• DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality, 2017-09-15

• Associations between Arsenic Species in Exfoliated Urothelial Cells and Prevalence of Diabetes among Residents of Chihuahua, Mexico, 2014-06-27

• Common and rare genetic markers of lipid variation in subjects with type 2 diabetes from the ACCORD clinical trial, 2017-05-02

• Glucose-responsive insulin and delivery systems: innovation and translation, 2019-08-18

• Real-world evidence: the devil is in the detail, 2020-07-15

• A Mixed-Methods, Randomized Clinical Trial to Examine Feasibility of a Mindfulness-Based Stress Management and Diabetes Risk Reduction Intervention for African Americans with Prediabetes, 2019-08-14

• Identification of clinically-relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c, 2019-04-29

• 4300 Evaluation and structure of the pilot funding program at the University of North Carolina CTSA Hub (NC TraCS), 2020-06-01

• No increased risk of cardiovascular events in older adults initiating dipeptidyl peptidase 4 inhibitors versus therapeutic alternatives, 2017-03-17

• Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies, 2021-08-15